Home > Insider Trading > Filing (0001209191-19-049089)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1379344	Laurent Fischer	C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-09-06	1,720	$10.71	1,720	No	4	P	Direct
Common Stock	Acquisiton	2019-09-09	1,670	$10.54	3,390	No	4	P	Direct
Common Stock	Acquisiton	2019-09-09	300	$11.30	3,690	No	4	P	Direct
Common Stock	Acquisiton	2019-09-10	960	$10.29	4,650	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The weighted average purchase price for the transaction reported was $10.7147, and the range of prices were between $10.50 and $10.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
The weighted average purchase price for the transaction reported was $10.54, and the range of prices were between $10.13 and $11.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
The weighted average purchase price for the transaction reported was $10.2932, and the range of prices were between $9.91 and $10.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.